These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3293456)

  • 1. A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.
    Stehman FB; Bundy BN; Keys H; Currie JL; Mortel R; Creasman WT
    Am J Obstet Gynecol; 1988 Jul; 159(1):87-94. PubMed ID: 3293456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy with or without misonidazole for patients with stage IIIB or stage IVA squamous cell carcinoma of the uterine cervix: preliminary report of a Radiation Therapy Oncology Group randomized trial.
    Leibel S; Bauer M; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Pakuris E; Conner N
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):541-9. PubMed ID: 3104249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
    Stehman FB; Bundy BN; Thomas G; Keys HM; d'Ablaing G; Fowler WC; Mortel R; Creasman WT
    J Clin Oncol; 1993 Aug; 11(8):1523-8. PubMed ID: 8336190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
    Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
    J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: an RTOG randomized trial.
    Bauer M; Leibel S; Wasserman T; Marcial V; Rotman M; Hornback N; Cooper J; Gillespie B; Conner N; Pakuris E
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1101-3. PubMed ID: 3528087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.
    Piver M; Khalil M; Emrich LJ
    J Surg Oncol; 1989 Oct; 42(2):120-5. PubMed ID: 2796346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III study on the treatment of women with cervical cancer, stage IIB, IIIB, and IVA (confined to the pelvis and/or periaortic nodes), with radiotherapy alone versus radiotherapy plus immunotherapy with intravenous Corynebacterium parvum: a Gynecologic Oncology Group Study.
    DiSaia PJ; Bundy BN; Curry SL; Schlaerth J; Thigpen JT
    Gynecol Oncol; 1987 Mar; 26(3):386-97. PubMed ID: 3549476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
    Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical irradiation and misonidazole in the treatment of advanced cervical carcinoma: results of a phase II trial.
    Girinski T; Pejovic MH; Haie C; Bonnay M; Gerbaulet A; Mazeron JJ; Malaise E; Chassagne D
    Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1783-7. PubMed ID: 4044341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.
    Piver MS; Krishnamsetty RM; Emrich LJ
    Am J Obstet Gynecol; 1985 Apr; 151(8):1006-8. PubMed ID: 3985061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.
    Simpson JR; Bauer M; Perez CA; Wasserman TH; Emami B; Doggett RL; Byhardt RW; Phillips TL; Mowry PA
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1483-91. PubMed ID: 2542197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study.
    Piver MS; Barlow JJ; Vongtama V; Blumenson L
    Am J Obstet Gynecol; 1983 Dec; 147(7):803-8. PubMed ID: 6359885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
    Overgaard J; Bentzen SM; Kolstad P; Kjoerstad K; Davy M; Bertelsen K; Mäntyla M; Frankendal B; Skryten A; Löftquist I
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1069-72. PubMed ID: 2649463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
    N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).
    Lee DJ; Pajak TF; Stetz J; Order SE; Weissberg JB; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):465-70. PubMed ID: 2646255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
    Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
    Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.
    Piver MS; Vongtama V; Emrich LJ
    J Surg Oncol; 1987 Jun; 35(2):129-34. PubMed ID: 3108586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.